Ameriprise Financial Inc. Has $17.10 Million Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Ameriprise Financial Inc. lifted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 209.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 431,225 shares of the company's stock after purchasing an additional 291,671 shares during the period. Ameriprise Financial Inc. owned 0.46% of Acadia Healthcare worth $17,098,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the business. Algert Global LLC acquired a new position in shares of Acadia Healthcare during the fourth quarter worth $334,000. Aryeh Capital Management Ltd. acquired a new position in shares of Acadia Healthcare during the fourth quarter worth $10,860,000. Caisse DE Depot ET Placement DU Quebec acquired a new position in Acadia Healthcare in the fourth quarter valued at $4,480,000. Freestone Grove Partners LP bought a new stake in Acadia Healthcare during the fourth quarter valued at $29,943,000. Finally, 8 Knots Management LLC boosted its position in Acadia Healthcare by 28.9% during the fourth quarter. 8 Knots Management LLC now owns 656,963 shares of the company's stock valued at $26,049,000 after acquiring an additional 147,351 shares during the last quarter.

Acadia Healthcare Stock Down 2.3%

Shares of NASDAQ ACHC traded down $0.55 during trading on Thursday, hitting $22.96. 1,584,017 shares of the company traded hands, compared to its average volume of 1,715,151. The business's fifty day moving average is $25.83 and its 200 day moving average is $35.09. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.36 and a fifty-two week high of $82.41. The firm has a market capitalization of $2.12 billion, a price-to-earnings ratio of 7.53, a P/E/G ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same quarter in the prior year, the business earned $0.84 earnings per share. The business's quarterly revenue was up .3% compared to the same quarter last year. Equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have commented on ACHC shares. Royal Bank of Canada cut their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday. Mizuho cut their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Bank of America cut their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Finally, KeyCorp cut their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $47.94.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.